opioid
Indivior rocked by loss of patent case
March 23, 2018Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical
Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
Rising levels of opioid prescriptions puts NHS under pressure
March 16, 2018Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …
Purdue pulls plug on opioid marketing
February 13, 2018Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …
EU approves opioid treatment, amid fears of US-like crisis
November 22, 2017Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical
The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
FDA approves electronic nerve stimulator for opioid withdrawal
November 16, 2017Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …
Record number of drug-related deaths, as opioid crisis hits UK
August 2, 2017Medical Communications, Research and Development biotech, drug deaths, drugs, fentanyl, opioid, pharma, pharmaceutical
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, …
FDA Chief plans regulatory overhaul to tackle US opioid crisis
July 25, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, biotech, drugs, healthcare, opioid, pharma, pharmaceutical
The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …
Independent panel advise FDA to apply different framework to opioid painkillers
July 14, 2017Medical Communications FDA, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …
FDA to review effectiveness of abuse deterrent opioid drugs
June 14, 2017Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid, opioid crisis
FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …
New method discovered to target chronic pain
June 1, 2017Research and Development opioid, painkillers
Chronic pain is notoriously difficult to treat and can lead some people to take painkillers of increasing strength to combat …
Ohio takes legal action against pharma companies for opioid crisis
June 1, 2017Medical Communications Ohio, opioid, opioid crisis
If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …
Opioid crisis “highest initial priority” for new FDA Commissioner
May 24, 2017Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis
Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …
FDA restricts administration of strong pain killers to children
April 21, 2017Medical Communications, Sales and Marketing FDA, opioid
The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest …
US city takes drug company to court over opioid crisis
March 16, 2017Medical Communications OxyContin, opioid, opioid crisis
The opioid crisis in North America continues to rumble on, ruining lives and causing untold damage to communities. One city, …
Potential treatment for opioid withdrawal discovered
February 1, 2017Medical Communications, Research and Development University of Calgary, gout, opioid
Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
